Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Mathematical modelling of the impact of adolescent/adult tuberculosis vaccines to inform global, national, and subnational policy and delivery.
CLARK, RA;
2023
(2023). 10.17037/PUBS.04671751.
Guiding pragmatic treatment choices for rifampicin-resistant tuberculosis in the absence of second-line drug susceptibility testing.
Achar, J; Seddon, JA; KNIGHT, GM; Dodd, PJ; Esmail, H; Hughes, J; MCQUAID, CF;
2023
The European Respiratory Journal, (2023).62 5 10.1183/13993003.00969-2023.
Prevalence of mental distress in adults with and without a history of tuberculosis in an urban Zambian community.
Mainga, T; SCHAAP, A; SCHERER, N; MACTAGGART, I; Shanaube, K; AYLES, H; BOND, V; Stewart, RC;
2023
Global mental health (Cambridge, England), (2023).10, 10.1017/gmh.2023.83.
Development and description of a theory-driven, evidence-based, complex intervention to improve adherence to treatment for tuberculosis in the UK: the IMPACT study.
Jones, AS K; Horne, R; White, J; Costello, T; Darvell, M; Karat, AS; Kielmann, K; STAGG, HR; Hill, AT; Kunst, H; Campbell, CN J; Lipman, MC I;
2023
Health Psychology and Behavioral Medicine, (2023).12 1 10.1080/21642850.2023.2277289.
Safety and immunogenicity of ChAdOx1 85A prime followed by MVA85A boost compared with BCG revaccination among Ugandan adolescents who received BCG at birth: a randomised, open-label trial.
WAJJA, A; Nassanga, B; NATUKUNDA, A; Serubanja, J; Tumusiime, J; Akurut, H; Oduru, G; Nassuuna, J; Kabagenyi, J; Morrison, H; Scott, H; Doherty, RP; Marshall, JL; Puig, IC; COSE, S; KALEEBU, P; WEBB, EL; Satti, I; McShane, H; ELLIOTT, AM; TB042 Study Team,;
2023
The Lancet. Infectious diseases, (2023).24 3 10.1016/S1473-3099(23)00501-7.
Malnutrition in older adults: a wider view.
MCQUAID, CF; Bhargava, M; Sinha, P; Bhargava, A; HOUBEN, RM G J;
2023
Lancet, (2023).402 10416 10.1016/S0140-6736(23)01781-6.
Organisation of care for people receiving drug-resistant tuberculosis treatment in South Africa: a mixed methods study.
Dickson, L; Le Roux, SR; Mitrani, L; Hill, J; Jassat, W; Cox, H; Mlisana, K; Black, J; Loveday, M; GRANT, A; Kielmann, K; Ndjeka, N; Moshabela, M; Nicol, M;
2023
BMJ open, (2023).13 11 10.1136/bmjopen-2022-067121.
Beyond latent and active tuberculosis: a scoping review of conceptual frameworks.
Zaidi, SM A; Coussens, AK; Seddon, JA; Kredo, T; Warner, D; HOUBEN, RM G J; Esmail, H;
2023
eClinicalMedicine, (2023).66, 10.1016/j.eclinm.2023.102332.
Short oral regimens for pulmonary rifampicin-resistant tuberculosis (TB-PRACTECAL): an open-label, randomised, controlled, phase 2B-3, multi-arm, multicentre, non-inferiority trial.
Nyang'wa, B-T; Berry, C; Kazounis, E; Motta, I; Parpieva, N; Tigay, Z; Moodliar, R; DODD, M; Solodovnikova, V; Liverko, I; Rajaram, S; Rassool, M; McHugh, T; Spigelman, M; MOORE, DA; Ritmeijer, K; Du Cros, P; FIELDING, K; TB-PRACTECAL team,;
2023
The Lancet. Respiratory medicine, (2023).12 2 10.1016/S2213-2600(23)00389-2.
Treatment for radiographically active, sputum culture-negative pulmonary tuberculosis: A systematic review and meta-analysis.
Gray, AT; Macpherson, L; Carlin, F; Sossen, B; RICHARDS, AS; Kik, SV; HOUBEN, RM G J; MacPherson, P; Quartagno, M; Rogozińska, E; Esmail, H;
2023
PloS one, (2023).18 11 10.1371/journal.pone.0293535.